- 著者
- Yuya KAMATAKI Yusuke KAMEDA Yasuyo KITA Ichiro MATSUDA Susumu ITOH
- 出版者
- The Institute of Electronics, Information and Communication Engineers
- 雑誌
- IEICE Transactions on Information and Systems (ISSN:09168532)
- 巻号頁・発行日
- vol.E104.D, no.10, pp.1572-1575, 2021-10-01 (Released:2021-10-01)
- 参考文献数
- 11
- 被引用文献数
- 1
This paper proposes a lossless coding method for HDR color images stored in a floating point format called Radiance RGBE. In this method, three mantissa and a common exponent parts, each of which is represented in 8-bit depth, are encoded using the block-adaptive prediction technique with some modifications considering the data structure.
- 著者
- Yuta MITOBE Ken-ichiro MATSUDA Yukihiko SONODA
- 出版者
- The Japan Neurosurgical Society
- 雑誌
- Neurologia medico-chirurgica (ISSN:04708105)
- 巻号頁・発行日
- pp.2022-0179, (Released:2023-01-20)
- 参考文献数
- 26
Serum soluble interleukin-2 receptor (sIL-2R) is a practical tumor marker that is elevated in hematogenous tumors. The purpose of this study was to determine the usefulness of serum sIL-2R for differentiating among malignant brain tumors, including primary central nervous system lymphoma (PCNSL) and secondary central nervous system lymphoma (SCNSL). This study retrospectively investigated the sIL-2R levels in 130 patients with various types of malignant brain tumors, including PCNSL patients (n = 48) and SCNSL (n = 8); metastatic brain tumors (MTs, n = 16); and glioblastoma (GBM, n = 58). The median sIL-2R level (U/mL) of the PCNSL, SCNSL, MTs, and GBM groups were 489.7, 1024.8, 413.3, and 332.7 respectively. The sIL-2R level was significantly higher in the SCNSL group than in the PCNSL or other groups. The area under the ROC curve generated from the sIL-2R level was 0.826 (sensitivity: 0.875, specificity: 0.667, cutoff value: 521 U/mL) for differentiating SCNSL from PCNSL and 0.685 (sensitivity: 0.667, specificity: 0.707, cutoff value: 342 U/mL) for differentiating PCNSL from GBM. Measurement of sIL-2R level was convenient and useful to differentiate between SCNSL and PCSNL, both of which demand different treatment strategies.